Loading organizations...
Loading organizations...
Developing small molecule therapeutics for protein homeostasis disorders.
Proteostasis Therapeutics has raised $37.0M across 1 funding round.
Proteostasis Therapeutics has raised $37.0M in total across 1 funding round.
Proteostasis Therapeutics has raised $37.0M in total across 1 funding round.
Proteostasis Therapeutics's investors include Bihua Chen, dRx Capital, Elan Science One, F-Prime Capital, HealthCare Ventures, New Enterprise Associates, Rock Springs Capital, Sanofi Ventures.
Proteostasis Therapeutics has raised $37.0M across 1 funding round. Most recently, it raised $37.0M Series B in September 2015.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Sep 8, 2015 | $37.0M Series B | Bihua Chen | dRx Capital, Elan Science One, F-Prime Capital, HealthCare Ventures, New Enterprise Associates, Rock Springs Capital, Sanofi Ventures |